Inventor
LABRIJN ARAN FRANK
NL35 patents
⚠️ This page may combine multiple inventors who share the name “LABRIJN ARAN FRANK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENMAB AS
19 patentsUS10597464B2Mar 24, 2020
Heterodimeric antibody Fc-containing proteins and methods for production thereof
GENMAB AS35 citations93
US10590206B2Mar 17, 2020
Inert format
GENMAB AS29 citations93
US10407501B2Sep 10, 2019
Humanized or chimeric CD3 antibodies
GENMAB AS15 citations93
US10344050B2Jul 9, 2019
Production of heterodimeric proteins
GENMAB AS40 citations91
US11866514B2Jan 9, 2024
Heterodimeric antibody Fc-containing proteins and methods for production thereof
GENMAB AS5 citations85
US11485796B2Nov 1, 2022
Inert format
GENMAB AS6 citations85
US10906991B2Feb 2, 2021
Bispecific antibodies and methods for production thereof
GENMAB AS15 citations84
US9657107B2May 23, 2017
Monoclonal antibodies against c-Met
GENMAB AS9 citations84
US11492371B2Nov 8, 2022
Production of heterodimeric proteins
GENMAB AS9 citations83
US11613575B2Mar 28, 2023
Humanized or chimeric CD3 antibodies
GENMAB AS4 citations74
US11046771B2Jun 29, 2021
Monoclonal antibodies against HER2
GENMAB AS2 citations72
US10351629B2Jul 16, 2019
Recombinant IgG4 monovalent antibodies
GENMAB AS2 citations72
US11578141B2Feb 14, 2023
Bispecific antibodies against HER2 and CD3
GENMAB AS1 citations62
US11512140B2Nov 29, 2022
Monoclonal antibodies against c-Met
GENMAB AS0 citations62
US12247065B2Mar 11, 2025
Method for producing a controlled mixture of two or more different antibodies
GENMAB AS1 citations61
US11091553B2Aug 17, 2021
Monoclonal antibodies against HER2
GENMAB AS1 citations61
US10000570B2Jun 19, 2018
Antibody variants having modifications in the constant region
GENMAB AS1 citations51
US9663578B2May 30, 2017
Monoclonal antibodies against CD32b
GENMAB AS1 citations49
US12398214B2Aug 26, 2025
Binding agents binding to EpCAM and CD137
GENMAB AS0 citations44